Logo image of ALISP.PA

ISPD NETWORK (ALISP.PA) Stock Fundamental Analysis

EPA:ALISP - Euronext Paris - Matif - ES0109429037 - Common Stock - Currency: EUR

2.63  0 (0%)

Fundamental Rating

3

Taking everything into account, ALISP scores 3 out of 10 in our fundamental rating. ALISP was compared to 61 industry peers in the Media industry. ALISP has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, ALISP is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

ALISP had negative earnings in the past year.
In the past year ALISP had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ALISP reported negative net income in multiple years.
In multiple years ALISP reported negative operating cash flow during the last 5 years.
ALISP.PA Yearly Net Income VS EBIT VS OCF VS FCFALISP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M

1.2 Ratios

The Return On Assets of ALISP (-0.68%) is worse than 72.13% of its industry peers.
ALISP has a Return On Equity of -13.52%. This is in the lower half of the industry: ALISP underperforms 73.77% of its industry peers.
The Return On Invested Capital of ALISP (7.10%) is better than 62.30% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALISP is significantly above the industry average of 8.60%.
The last Return On Invested Capital (7.10%) for ALISP is well below the 3 year average (21.85%), which needs to be investigated, but indicates that ALISP had better years and this may not be a problem.
Industry RankSector Rank
ROA -0.68%
ROE -13.52%
ROIC 7.1%
ROA(3y)5.3%
ROA(5y)0.66%
ROE(3y)93.18%
ROE(5y)N/A
ROIC(3y)21.85%
ROIC(5y)N/A
ALISP.PA Yearly ROA, ROE, ROICALISP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 50 100 150

1.3 Margins

In the last couple of years the Profit Margin of ALISP has declined.
ALISP has a worse Operating Margin (1.09%) than 65.57% of its industry peers.
ALISP's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 33.87%, ALISP is doing worse than 73.77% of the companies in the same industry.
In the last couple of years the Gross Margin of ALISP has declined.
Industry RankSector Rank
OM 1.09%
PM (TTM) N/A
GM 33.87%
OM growth 3Y39.74%
OM growth 5Y-18.2%
PM growth 3YN/A
PM growth 5Y-24.31%
GM growth 3Y0.14%
GM growth 5Y-5.93%
ALISP.PA Yearly Profit, Operating, Gross MarginsALISP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40 50

More info and screens

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ALISP is creating value.
Compared to 1 year ago, ALISP has about the same amount of shares outstanding.
ALISP has more shares outstanding than it did 5 years ago.
ALISP has a better debt/assets ratio than last year.
ALISP.PA Yearly Shares OutstandingALISP.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M
ALISP.PA Yearly Total Debt VS Total AssetsALISP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

ALISP has an Altman-Z score of 2.55. This is not the best score and indicates that ALISP is in the grey zone with still only limited risk for bankruptcy at the moment.
ALISP has a better Altman-Z score (2.55) than 83.61% of its industry peers.
ALISP has a debt to FCF ratio of 7.33. This is a slightly negative value and a sign of low solvency as ALISP would need 7.33 years to pay back of all of its debts.
ALISP has a Debt to FCF ratio (7.33) which is comparable to the rest of the industry.
A Debt/Equity ratio of 1.49 is on the high side and indicates that ALISP has dependencies on debt financing.
The Debt to Equity ratio of ALISP (1.49) is worse than 65.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.49
Debt/FCF 7.33
Altman-Z 2.55
ROIC/WACC0.93
WACC7.62%
ALISP.PA Yearly LT Debt VS Equity VS FCFALISP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M 15M

2.3 Liquidity

ALISP has a Current Ratio of 0.91. This is a bad value and indicates that ALISP is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.91, ALISP perfoms like the industry average, outperforming 45.90% of the companies in the same industry.
A Quick Ratio of 0.91 indicates that ALISP may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.91, ALISP is in line with its industry, outperforming 52.46% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.91
ALISP.PA Yearly Current Assets VS Current LiabilitesALISP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

6

3. Growth

3.1 Past

ALISP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -117.94%.
The earnings per share for ALISP have been decreasing by -20.33% on average. This is quite bad
Looking at the last year, ALISP shows a very strong growth in Revenue. The Revenue has grown by 27.55%.
ALISP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.52% yearly.
EPS 1Y (TTM)-117.94%
EPS 3YN/A
EPS 5Y-20.33%
EPS Q2Q%-600.8%
Revenue 1Y (TTM)27.55%
Revenue growth 3Y37.03%
Revenue growth 5Y36.52%
Sales Q2Q%18.78%

3.2 Future

The Earnings Per Share is expected to grow by 17.79% on average over the next years. This is quite good.
ALISP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.76% yearly.
EPS Next Y-90.24%
EPS Next 2Y7.07%
EPS Next 3Y17.79%
EPS Next 5YN/A
Revenue Next Year23.65%
Revenue Next 2Y17.25%
Revenue Next 3Y14.92%
Revenue Next 5Y8.76%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALISP.PA Yearly Revenue VS EstimatesALISP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M 200M
ALISP.PA Yearly EPS VS EstimatesALISP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 0.4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALISP. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 10.87, the valuation of ALISP can be described as very reasonable.
62.30% of the companies in the same industry are more expensive than ALISP, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.42, ALISP is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 10.87
ALISP.PA Price Earnings VS Forward Price EarningsALISP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALISP indicates a slightly more expensive valuation: ALISP is more expensive than 65.57% of the companies listed in the same industry.
ALISP's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 16.32
EV/EBITDA 18.63
ALISP.PA Per share dataALISP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

A more expensive valuation may be justified as ALISP's earnings are expected to grow with 17.79% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.07%
EPS Next 3Y17.79%

More info and screens

0

5. Dividend

5.1 Amount

ALISP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ISPD NETWORK

EPA:ALISP (5/8/2025, 7:00:00 PM)

2.63

0 (0%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)07-24 2024-07-24
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap39.16M
Analysts88
Price Target5.15 (95.82%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.81%
PT rev (3m)-3.81%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)133.33%
EPS NY rev (3m)-88.24%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.91%
Revenue NY rev (3m)2.22%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.87
P/S 0.26
P/FCF 16.32
P/OCF 9.12
P/B 11.02
P/tB N/A
EV/EBITDA 18.63
EPS(TTM)-0.03
EYN/A
EPS(NY)0.24
Fwd EY9.2%
FCF(TTM)0.16
FCFY6.13%
OCF(TTM)0.29
OCFY10.96%
SpS10.13
BVpS0.24
TBVpS-0.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.68%
ROE -13.52%
ROCE 9.82%
ROIC 7.1%
ROICexc 11.44%
ROICexgc N/A
OM 1.09%
PM (TTM) N/A
GM 33.87%
FCFM 1.59%
ROA(3y)5.3%
ROA(5y)0.66%
ROE(3y)93.18%
ROE(5y)N/A
ROIC(3y)21.85%
ROIC(5y)N/A
ROICexc(3y)254.41%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)30.22%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y83.3%
ROICexc growth 5Y18.96%
OM growth 3Y39.74%
OM growth 5Y-18.2%
PM growth 3YN/A
PM growth 5Y-24.31%
GM growth 3Y0.14%
GM growth 5Y-5.93%
F-Score4
Asset Turnover2.13
Health
Industry RankSector Rank
Debt/Equity 1.49
Debt/FCF 7.33
Debt/EBITDA 1.96
Cap/Depr 178.83%
Cap/Sales 1.25%
Interest Coverage 1.65
Cash Conversion 158.72%
Profit Quality N/A
Current Ratio 0.91
Quick Ratio 0.91
Altman-Z 2.55
F-Score4
WACC7.62%
ROIC/WACC0.93
Cap/Depr(3y)93.32%
Cap/Depr(5y)73.86%
Cap/Sales(3y)0.91%
Cap/Sales(5y)1.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-117.94%
EPS 3YN/A
EPS 5Y-20.33%
EPS Q2Q%-600.8%
EPS Next Y-90.24%
EPS Next 2Y7.07%
EPS Next 3Y17.79%
EPS Next 5YN/A
Revenue 1Y (TTM)27.55%
Revenue growth 3Y37.03%
Revenue growth 5Y36.52%
Sales Q2Q%18.78%
Revenue Next Year23.65%
Revenue Next 2Y17.25%
Revenue Next 3Y14.92%
Revenue Next 5Y8.76%
EBIT growth 1Y-68.7%
EBIT growth 3Y91.48%
EBIT growth 5Y11.67%
EBIT Next Year-43.74%
EBIT Next 3Y13.79%
EBIT Next 5YN/A
FCF growth 1Y212.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15012.3%
OCF growth 3YN/A
OCF growth 5YN/A